Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Encephalopathy Treatment Market 2019-2023 - Rise in Initiatives to Increase the Awareness About Encephalopathy Disease Management and Effective Treatment of Encephalopathy - ResearchAndMarkets.com

Research and Markets
Posted on: 06 Dec 18

The "Global Encephalopathy Treatment Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

The Global Encephalopathy Treatment Market is projected to grow at a CAGR of 4.75% during the period 2019-2023.

The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend affecting this market is the emergence of novel treatment targets for encephalopathy. Certain candidates are under investigation for the treatment of liver cirrhosis which is one of the leading causes of hepatic encephalopathy.

According to the report, one driver influencing this market is the rise in initiatives to increase the awareness about encephalopathy disease management and effective treatment of encephalopathy. Most of the programs aim at providing co-pay assistance, educational material for hepatic encephalopathy, and treatment adherence support. The growing availability of such patient awareness programs for assistance in the management and treatment of encephalopathy is expected to boost the growth of the global encephalopathy market.

Further, the report states that one challenge affecting this market is the adverse side effects associated with available drugs. The growth of the market is impeded by the adverse side effects such as severe stomach pain, diarrhea, and flatulence due to the available drugs for the treatment of encephalopathy.

Market Trends

  • Emergence of Novel Treatment Targets for Encephalopathy
  • Increase in FDA Drug Approval for Diseases Associated with Encephalopathy
  • Increase in Adoption of Technological Advances for Treating Encephalopathy

Key Vendor

  • Bausch Health

Topics Covered

1. Executive Summary

2. Scope of the Report

3. Market Landscape

4. Pipeline Analysis

5. Market Sizing

6. Five Forces Analysis

7. Market Segmentation by Type

8. Customer Landscape

9. Geographic Landscape

10. Decision Framework

11. Drivers and Challenges

12. Market Trends

13. Vendor Landscape

14. Vendor Analysis

For more information about this report visit https://www.researchandmarkets.com/research/38lc3q/global?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181206005764/en/

Business Wire
www.businesswire.com

Last updated on: 06/12/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.